Clorox (NYSE:CLX) Price Target Raised to $117.00 at JPMorgan Chase & Co.

Clorox (NYSE:CLX) had its price objective boosted by analysts at JPMorgan Chase & Co. from $114.00 to $117.00 in a research note issued to investors on Wednesday,MarketScreener reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential downside of 0.18% from the stock’s current price.

CLX has been the subject of several other reports. Wall Street Zen lowered Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, January 24th. Jefferies Financial Group lowered their target price on shares of Clorox from $152.00 to $151.00 and set a “buy” rating on the stock in a research note on Wednesday. Rothschild & Co Redburn reduced their target price on Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Evercore ISI dropped their price objective on Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Clorox from $114.00 to $112.00 and set a “hold” rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, Clorox presently has an average rating of “Reduce” and an average target price of $118.67.

Clorox Stock Performance

Shares of CLX stock traded up $2.23 on Wednesday, hitting $117.21. 523,294 shares of the stock traded hands, compared to its average volume of 2,218,748. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. Clorox has a 1-year low of $96.66 and a 1-year high of $159.04. The company’s fifty day moving average is $105.19 and its 200 day moving average is $113.96. The company has a market capitalization of $14.30 billion, a PE ratio of 18.42, a PEG ratio of 0.56 and a beta of 0.59.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business’s revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.55 earnings per share. On average, equities research analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The stock was bought at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Hedge Funds Weigh In On Clorox

Several hedge funds have recently bought and sold shares of CLX. Total Investment Management Inc. acquired a new stake in shares of Clorox in the 2nd quarter valued at $25,000. Center for Financial Planning Inc. acquired a new stake in Clorox in the third quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC bought a new position in Clorox in the third quarter valued at about $25,000. NewSquare Capital LLC boosted its stake in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares in the last quarter. Finally, True Wealth Design LLC increased its position in Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 204 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly topped Street expectations and operating cash flow showed improvement versus a year ago, giving some near-term fundamental support. Clorox Company (CLX) Stock Falls on Q2 2026 Earnings
• Positive Sentiment: Bullish write-ups argue valuation (forward P/E ~18) and dividend yield make CLX attractive for income investors if management can stabilize volumes and margins. The Clorox Company (CLX): A Bull Case Theory
• Neutral Sentiment: Management hosted its Q2 earnings call and confirmed its outlook; read the transcript for detail on pricing, cost actions and working-capital plans. Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Company press release reiterated results and the outlook — confirmation reduces surprise risk but left execution questions. Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook
• Negative Sentiment: Adjusted EPS missed consensus ($1.39 vs. ~$1.43), driven by higher costs and weaker volume in core cleaning categories — a clear short-term headwind for the share price. Clorox misses quarterly profit estimates
• Negative Sentiment: Management warned of an inventory reset in 2026 that could squeeze profits further — this forward-looking risk is a significant reason for near-term caution. Clorox Faces Profit Squeeze From Inventory Reset In 2026
• Negative Sentiment: Analysts and media highlighted muted demand and shoppers trading down to cheaper alternatives; some shops have cut targets and at least one major firm has an underweight view — pressure on consensus estimates may persist. Clorox Posts Lower Profit on Sales Volume Declines

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.